|
Vivimed Labs Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
56.22 Cr.
|
P/BV
|
-0.77
|
Book Value (Rs.)
|
-8.82
|
|
52 Week High/Low (Rs.)
|
29/5
|
FV/ML
|
2/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
03/01/2025
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 116.27 | 149.07 | 187.10 | 236.57 | 841.22 |
| Other Operating Revenues | 0.00 | 0.00 | 0.00 | 0.72 | 20.25 |
| Total Operating Revenues | 116.27 | 149.07 | 187.10 | 237.29 | 861.47 |
| | | | | | |
| Other Income | 4.37 | 9.98 | 0.97 | 1.27 | 9.82 |
| Total Revenue | 120.64 | 159.05 | 188.07 | 238.56 | 871.29 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 57.76 | 89.55 | 187.09 | 153.00 | 357.82 |
| Purchase Of Stock-In Trade | 5.67 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating And Direct Expenses | 1.98 | 16.47 | 17.55 | 28.06 | 185.15 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -3.58 | -18.07 | 84.42 | 0.49 | -3.29 |
| Employee Benefit Expenses | 28.39 | 34.16 | 32.67 | 36.22 | 189.75 |
| Finance Costs | 2.95 | 2.43 | 35.90 | 39.76 | 53.88 |
| Depreciation And Amortisation Expenses | 20.22 | 19.94 | 108.41 | 18.28 | 55.50 |
| Other Expenses | 39.09 | 54.57 | 52.68 | 27.58 | 102.36 |
| Total Expenses | 152.49 | 199.04 | 518.72 | 303.39 | 941.15 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -31.85 | -39.99 | -330.65 | -64.83 | -69.86 |
| | | | | | |
| Profit/Loss Before Tax | -31.85 | -39.99 | -330.65 | -64.83 | -69.86 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 0.23 | 0.00 | 0.00 | 0.00 | 3.37 |
| Deferred Tax | -0.11 | -0.40 | -2.12 | 2.82 | -1.34 |
| Tax For Earlier Years | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 |
| Total Tax Expenses | 0.11 | -0.38 | -2.12 | 2.82 | 2.03 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | -31.96 | -39.62 | -328.53 | -67.65 | -71.89 |
| | | | | | |
| Prior Period Items | 0.00 | -5.83 | 0.00 | 0.00 | 0.00 |
| Profit/Loss From Continuing Operations | -31.96 | -45.45 | -328.53 | -67.65 | -71.89 |
| | | | | | |
| Profit/Loss For The Period | -31.96 | -45.45 | -328.53 | -67.65 | -71.89 |
| Consolidated Profit/Loss After MI And Associates | -31.96 | -45.45 | -328.53 | -67.65 | -71.89 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | -3.85 | -5.48 | -39.62 | -8.16 | -8.67 |
| Diluted EPS (Rs.) | -3.74 | -5.32 | -39.62 | -7.92 | -8.42 |
